MHRA Drug Safety Update – June 2018

MHRA Drug Safety Update – June 2018

June 22, 2018

Date Issued: 22nd June 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 11, Issue 11, June 2018) has been published and includes articles on:

  • dolutegravir (Tivicay▼, Triumeq▼, Juluca▼): signal of increased risk of neural tube defects; do not prescribe to women seeking to become pregnant; exclude pregnancy before initiation and advise use of effective contraception;
  • letters sent to healthcare professionals in May 2018; and
  • Medical Device Alerts issued in May 2018.

To see the latest MHRA Drug Safety Update in full, visit the website.

Posted in:

More Latest News >

Christmas opening hours

Community pharmacy contractors do not have to open on days which are specifically mentioned in the Regulations (namely Christmas Day,...

FMD webinar now on-demand

Community pharmacy contractors can now access an online recording of PSNC’s recent webinar about the Falsified Medicines Directive (FMD). More than 1,000 people...